Atrás
Rango del Día
$87.99
$90.94
Rango de 52 Semanas
$79.52
$124.00
Volumen
1,191,903
Promedio 50D / 200D
$105.31
/
$104.33
Cierre Anterior
$89.27
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -20.4 | 0.4 |
| P/B | 1.2 | 2.9 |
| ROE % | -5.7 | 3.7 |
| Net Margin % | -39.6 | 3.8 |
| Rev Growth 5Y % | -38.3 | 10.0 |
| D/E | 0.0 | 0.2 |
Puntos Clave
Revenue declined -38.26% annually over 5 years
Debt/Equity of 0.01 — conservative balance sheet
Generating 269.81M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 38.46%
Capital efficient — spends only 6.10% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-38.26%
Revenue (1Y)0.20%
Earnings (1Y)N/A
FCF Growth (3Y)-75.95%
Calidad
Return on Equity
-5.65%
ROIC-2.40%
Net Margin-39.59%
Op. Margin-22.63%
Seguridad
Debt / Equity
0.01
Current Ratio7.54
Interest Coverage-45.74
Valoración
P/E Ratio
-20.36
P/B Ratio1.16
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0.20% | Revenue Growth (3Y) | -15.04% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -38.26% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2.76B | Net Income (TTM) | -1.09B |
| ROE | -5.65% | ROA | -4.96% |
| Gross Margin | 77.64% | Operating Margin | -22.63% |
| Net Margin | -39.59% | Free Cash Flow (TTM) | 269.81M |
| ROIC | -2.40% | FCF Growth (3Y) | -75.95% |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 7.54 |
| Interest Coverage | -45.74 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -20.36 | P/B Ratio | 1.16 |
| P/S Ratio | 8.06 | PEG Ratio | -0.29 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 22.22B | Enterprise Value | 14.81B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.76B | 2.75B | 3.82B | 17.31B | 18.98B |
| Net Income | -1.09B | -665.30M | 930.30M | 9.43B | 10.29B |
| EPS (Diluted) | -4.51 | -2.77 | 3.83 | 37.09 | 41.21 |
| Gross Profit | 2.14B | 2.21B | 3.22B | 14.32B | 16.07B |
| Operating Income | -623.87M | -1.31B | 690.40M | 12.64B | 15.28B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 21.98B | 22.53B | 23.01B | 23.28B | 15.83B |
| Total Liabilities | 2.76B | 3.12B | 2.76B | 3.22B | 3.94B |
| Shareholders' Equity | 19.22B | 19.41B | 20.25B | 20.06B | 11.89B |
| Total Debt | 267.29M | 254.20M | 219.10M | 212.20M | 301.50M |
| Cash & Equivalents | 7.67B | 9.76B | 11.66B | 13.88B | 1.69B |
| Current Assets | 16.14B | 18.80B | 19.53B | 21.92B | 15.07B |
| Current Liabilities | 2.14B | 2.52B | 2.07B | 2.95B | 3.48B |